Research and Markets: Hematopoietic Stem Cell Transplantation – Pipeline Review, H2 2012

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/ks4gfv/hematopoietic) has announced the addition of Global Markets Direct's new report "Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2012', provides an overview of the Hematopoietic Stem Cell Transplantation therapeutic pipeline. This report provides information on the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hematopoietic Stem Cell Transplantation.

Scope

- A snapshot of the global therapeutic scenario for Hematopoietic Stem Cell Transplantation.

- A review of the Hematopoietic Stem Cell Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Hematopoietic Stem Cell Transplantation pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

Read more from the original source:
Research and Markets: Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2012